Trials / Terminated
TerminatedNCT07036718
NIS PDC the Efficacy and Safety of Iptacopan in Adults in Routine Clinical Practice
A Prospective, Non-interventional Study to Evaluate the Efficacy and Safety of Iptacopan in Adults With Paroxysmal Nocturnal Hemoglobinuria (PNH) in Routine Clinical Practice in the Russian Federation
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 6 (actual)
- Sponsor
- Novartis Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective, non-interventional, multicenter study to evaluate the efficacy and safety of iptacopan in patients with PNH in real-world settings in Russia.
Conditions
Timeline
- Start date
- 2025-07-29
- Primary completion
- 2025-12-25
- Completion
- 2025-12-25
- First posted
- 2025-06-25
- Last updated
- 2026-04-13
Locations
5 sites across 1 country: Russia
Source: ClinicalTrials.gov record NCT07036718. Inclusion in this directory is not an endorsement.